Just a moment...Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial - The Lancet thelancet.com Submitted by thelancet4803 on January 18, 2024 at 11:40 PM in health No comments 15